Vitamin D microcapsules vs oil emulsions in dairy

In one comparison, vitamin D3 held in re-assembled casein micelles showed no significant loss after treatment at 80 °C for one minute, while vitamin D3 delivered through a Tween-80 emulsion lost 13%, and unencapsulated vitamin D3 lost 14%.

That gap is not merely a formulation detail. It affects how consistently a fortified product can deliver its intended nutrient dose, how confidently manufacturers can manage storage and processing, and whether a food fortification policy reaches communities facing nutritional inequity in a dependable way. When fortified dairy is expected to function as part of a population-level strategy, the delivery system becomes part of the policy itself.

The comparison between vitamin D3 microcapsules and oil emulsions is therefore not a simple contest between an older and a newer technology. Both systems can work. The practical question is where each system holds its advantage, under which processing conditions, and whether the available evidence is mature enough to support full industrial deployment.

Thermal resilience: what happens during pasteurization

Vitamin D3 is fat-soluble, which makes dairy a natural food vehicle but also creates a formulation challenge. The vitamin must be dispersed through the product in a way that supports uniform dosing, remains compatible with the dairy matrix, and limits degradation from heat, light, and oxidation. A basic oil emulsion can accomplish the first task, but it does not necessarily provide the same level of protection during thermal processing as a structured carrier.

Pasteurization is an especially important test because it places the nutrient inside a system that is already chemically active: proteins are changing conformation, fat droplets are interacting with the aqueous phase, and oxygen exposure can contribute to oxidation. The vitamin may remain present in the product while becoming less stable over subsequent storage, or it may degrade during the thermal step itself.

The available comparison at 80 °C for one minute illustrates the hierarchy clearly:

The result should not be expanded into a claim that all emulsions are inadequate. Oil-based systems vary according to the oil phase, droplet size, emulsifier, pH, oxygen exposure, homogenization conditions, and storage environment. A well-designed nanoemulsion may protect vitamin D3 substantially better than a conventional, unstructured dispersion. What the comparison does show is that the physical organization of the vitamin matters: the nutrient’s performance depends not only on its chemical identity but also on the barrier surrounding it.

This distinction becomes important when fortification targets are set on the assumption that the amount added is the amount delivered. In practice, the relevant question is closer to this: how much vitamin D3 remains available after mixing, thermal treatment, filling, distribution, and storage? If the answer is uncertain, manufacturers may compensate by adding more nutrient, but overage is not a substitute for a stable delivery system. It can complicate cost control, regulatory compliance, sensory performance, and dose consistency.

In food fortification, the nutrient dose is only as dependable as the process that carries it from the factory to the consumer.

Casein micelles and soy protein isolates: two different protection strategies

Microencapsulation is not one technology with one behavior. It is a family of approaches that place vitamin D3 inside, between, or alongside protective structures designed to reduce contact with destabilizing conditions. In dairy, casein-based carriers are particularly relevant because they are chemically and functionally related to the product matrix, while soy protein isolate offers a plant-protein route with its own interfacial and stabilizing properties.

Re-assembled casein micelles

Casein micelles are attractive as vitamin D carriers because they can create a protein-based environment around a fat-soluble compound without introducing a completely foreign structure into a dairy beverage. Re-assembled micelles can provide physical separation from the surrounding aqueous phase and may improve the vitamin’s resistance to heat and oxidation.

The heat-treatment result is the strongest point in the available evidence: vitamin D3 nanoencapsulated in re-assembled casein micelles showed no significant loss at 80 °C for one minute. That performance was better than both the Tween-80 emulsion and the unencapsulated vitamin D3 tested under the same condition.

The advantage is not necessarily that casein micelles make vitamin D3 invulnerable. Rather, they create a more controlled microenvironment during a short but consequential processing event. For dairy manufacturers, that can matter because the carrier is expected to survive not only the heating step but also pumping, homogenization, filling, refrigeration, and the product’s shelf life.

Soy protein isolate emulsions

Soy protein isolate emulsions use proteins as stabilizing agents around oil droplets containing vitamin D3. Under a reported set of conditions—4 wt% soy protein isolate, pH 7, and 25 °C—the system provided up to 85% protection against vitamin D degradation during processing.

That figure is meaningful, but it must be read with its conditions attached. It describes performance in a defined formulation environment, not a universal result for every soy-protein beverage or every dairy product. Protein concentration, pH, ionic strength, oil composition, oxygen exposure, and thermal history can all alter the behavior of the emulsion.

Still, the broader implication is useful: protein-based emulsification can move an oil-soluble vitamin from a vulnerable, poorly controlled state into a carrier system that offers measurable protection. It may also provide formulation flexibility where a manufacturer wants to work with a dispersed oil phase without committing to a more complex capsule architecture.

The two systems therefore represent different choices rather than interchangeable labels:

• Casein micelles are closely aligned with dairy chemistry and have shown strong resistance under the tested thermal treatment.
• Soy protein isolate emulsions can provide substantial protection under controlled pH, concentration, and temperature conditions, while potentially offering flexibility in non-dairy or mixed food systems.
• Basic oil emulsions may remain useful where manufacturing infrastructure, cost, or sensory requirements favor a simpler approach, particularly if the emulsion is optimized rather than treated as a generic carrier.
• Unencapsulated vitamin D3 leaves the nutrient more exposed to heat, oxidation, and storage-related degradation.

For nutritional equity, these distinctions have a practical consequence. A technology that performs well only in a narrow laboratory window may not serve communities reliably if local or regional manufacturers cannot reproduce that window at scale. Conversely, a simpler carrier that is stable enough under real processing conditions may produce more dependable public-health value than a sophisticated system that remains difficult to manufacture.

Storage stability: why the process does not end at the pasteurizer

Thermal resilience receives attention because it is easy to test: apply a defined temperature for a defined time and measure the remaining vitamin. Storage is less dramatic but often more revealing. A fortified dairy product may spend days or weeks moving through cold-chain conditions, retail distribution, and household refrigeration, and the nutrient must remain stable throughout that period.

The reported results for casein micelle carriers show how strongly processing history can shape storage performance. After approximately 28 days of cold storage, vitamin D3 in casein micelles treated with ultra-high-pressure homogenization at roughly 155 MPa experienced about 10% loss. Non-homogenized casein micelles experienced approximately 40% loss, while unencapsulated vitamin D3 lost about 70%.

The important point is not simply that pressure homogenization improved the result. It is that the carrier system and the manufacturing process worked together. A microcapsule or micelle is not a magic container whose performance remains constant regardless of how it is produced. Droplet size, interfacial structure, dispersion quality, and the distribution of the vitamin through the product can all be influenced by homogenization.

This is where laboratory claims often become difficult to translate into industrial practice. A formulation may be stable in a small batch under carefully controlled conditions, yet behave differently when a plant introduces longer residence times, variable shear, different oxygen levels, repeated pumping, or a larger thermal load. The relevant technology is therefore not just the encapsulating material. It is the complete nutrient delivery system:

• the vitamin D3 concentration and form;
• the oil or lipid phase carrying the vitamin;
• the protein, emulsifier, or wall material surrounding the droplets;
• homogenization pressure and number of passes;
• pH, ionic strength, and interaction with dairy proteins;
• exposure to oxygen and light;
• the temperature profile from processing through storage;
• the method used to quantify retained and bioaccessible vitamin D3.

The last point deserves emphasis. Measuring total vitamin D3 remaining in a product is not identical to measuring how much is released and available for absorption. Encapsulation may improve stability and bioaccessibility compared with unencapsulated forms, but the two outcomes should be evaluated separately. A carrier that preserves the molecule chemically but releases it poorly during digestion would not deliver the same nutritional value as one that performs well on both measures.

At present, comprehensive head-to-head clinical bioavailability trials comparing solid microcapsules and liquid nanoemulsions in identical dairy formulations remain limited. That gap should temper the language used around advanced delivery systems. Improved retention is an important engineering result; it is not automatically proof of superior population-level nutritional impact.

Oil phase selection: why soybean oil can outperform another oil

Oil emulsions are sometimes discussed as though they form one uniform category. They do not. The oil phase can affect oxidation, interfacial behavior, droplet stability, and the protection available to vitamin D3 during storage. This is particularly visible in nanoemulsions, where the small droplet size increases the interfacial area and makes the chemistry of that interface especially important.

In coconut yogurt nanoemulsions produced through the emulsion inversion point method, vitamin D3 retention reached 100% when soybean oil was used as the continuous phase after 28 days of storage. Under the same reported comparison, Brazil nut oil produced 63% retention. The result is a reminder that an oil-based delivery system should be evaluated as a formulation, not categorized as simply successful or unsuccessful because it uses an emulsion.

The reported nanoemulsions had droplet sizes in the range of 200–300 nanometers, with peroxide values of approximately 3.5–4 milliequivalents on day 28. Those measurements provide context for the retention result: the carrier’s physical size and oxidative state are part of the stability story, and the choice of oil can shift the balance.

This does not mean soybean oil is universally superior for every fortified dairy product. It means that, in the specified coconut-yogurt system and storage comparison, the soybean oil formulation retained more vitamin D3. A different product matrix, emulsifier, processing route, or oxygen exposure could produce a different ranking.

For product developers, the practical lesson is to avoid selecting an oil phase by habit. The oil should be screened alongside the complete formulation, with attention to:

1. Vitamin D3 retention during processing, not only immediately after preparation.

2. Oxidative stability during cold storage, including the behavior of the oil phase and the surrounding matrix.

3. Droplet-size distribution, since a nominal average can conceal an unstable tail of larger droplets.

4. Sensory effects, because rancidity, off-notes, or changes in mouthfeel can undermine consumer acceptance even when nutrient retention is high.

5. Compatibility with the food vehicle, particularly in acidic or protein-rich products.

6. Manufacturing reproducibility, because a formulation that depends on narrow laboratory conditions may be difficult to maintain on a production line.

The phrase “oil-soluble vitamin D food enrichment” can therefore hide a great deal of technical variation. The oil is not merely a solvent for the vitamin; it is part of the protection architecture.

Microcapsules versus oil emulsions: choosing by the real bottleneck

The central comparison becomes more useful when framed around the problem a manufacturer or public-health program is actually trying to solve. If heat exposure is the dominant risk, re-assembled casein micelles may offer a strong advantage under the tested conditions. If storage degradation is the main concern, pressure-assisted processing and oil-phase selection may matter as much as the choice between a capsule and an emulsion. If the product must be manufactured with limited equipment, a simpler, optimized emulsion may be more practical than a high-complexity encapsulation platform.

This table should not be read as a universal ranking. It is a route map. The most appropriate system depends on whether the limiting factor is pasteurization, oxidation, shelf life, cost, equipment, sensory quality, or regulatory consistency.

For public-health implementation, another factor enters the decision: the reliability of grassroots implementation. Fortification programs operate through supply chains, procurement systems, quality-control laboratories, labeling rules, and local production realities. A delivery system that performs beautifully in a controlled research setting but lacks validated kinetic data under industrial conditions can become a systemic barrier when introduced into a fragmented manufacturing environment.

That is why nutrient delivery systems for vitamin D need to be assessed beyond the question of whether they protect the vitamin in principle. Policymakers and manufacturers need evidence that the technology can deliver a reproducible dose across batches, remain stable through the intended shelf life, and function within the equipment and quality systems available to the producers who will actually make the food.

The scale-up gap: from promising carrier to dependable fortification tool

Many advanced carrier systems developed for vitamin D delivery in beverages have not yet achieved widespread industrial application, partly because kinetic data and process optimization under full manufacturing conditions remain limited. This is not a failure of the underlying science. It is a reminder that food fortification technology must pass through several layers of evidence before it can support a national or regional program.

At the laboratory stage, researchers can control temperature, mixing time, pH, oxygen exposure, ingredient quality, and storage conditions with considerable precision. At industrial scale, the formulation encounters variability: raw materials change between suppliers, production schedules compress residence times, cleaning cycles interrupt processes, and the final product may be exposed to light or temperature fluctuations that were absent from the research protocol.

A responsible development pathway should therefore connect five questions:

• Does the carrier protect vitamin D3 during the actual thermal profile used by the product?
• Does it preserve the nutrient through realistic cold storage and distribution?
• Can the manufacturer measure the nutrient accurately in the finished matrix?
• Does the encapsulated or emulsified vitamin become bioaccessible during digestion?
• Can the system be produced consistently without creating new cost, sensory, or equity barriers?

The fifth question is often treated as an afterthought, but it is central to nutritional equity. If a fortified dairy product becomes too expensive, too specialized, or too dependent on imported ingredients, the technology may widen the distance between populations that can access it and those that cannot. A technically superior carrier is not automatically the most equitable carrier.

We should also resist the opposite mistake: assuming that a familiar oil emulsion is automatically the pragmatic choice. If the formulation loses a substantial fraction of vitamin D3 during processing or storage, the apparent simplicity can conceal a delivery failure. The proper comparison is not between a sophisticated technology and a cheap one; it is between complete systems that are evaluated under the same conditions and judged against the same nutritional objective.

The strongest fortification platform is not the one with the most impressive laboratory label; it is the one that preserves a reliable dose through the entire chain of production and access.

What the evidence supports now

The current evidence supports several cautious conclusions.

First, encapsulation and structured emulsification can improve vitamin D3 stability compared with unencapsulated forms. The casein micelle results show particularly strong protection during the tested heat treatment, while soy protein isolate emulsions demonstrated up to 85% protection under defined conditions.

Second, conventional oil emulsions should not be dismissed as a single, failed category. Their performance depends on formulation. The soybean-oil nanoemulsion result, with complete reported vitamin D3 retention after 28 days in the specified coconut-yogurt system, demonstrates that oil-based systems can be highly effective when the oil phase and processing method are well chosen.

Third, processing intensity and design matter. Ultra-high-pressure homogenization at approximately 155 MPa was associated with far lower vitamin D3 loss during 28 days of cold storage in casein micelles than in non-homogenized micelles or unencapsulated vitamin D3. The carrier and the process cannot be separated when evaluating stability.

Fourth, the evidence is not yet sufficient to declare that microcapsules have replaced emulsions in industrial dairy production. Long-term data for specific commercial microcapsule products in full-scale plants remain limited, and direct clinical comparisons of bioavailability between solid microcapsules and liquid nanoemulsions in identical dairy products are still lacking.

For researchers, the next priority is not another isolated retention experiment. It is a connected body of evidence that follows the same formulation from production through storage and digestion, while documenting the process parameters needed for reproducibility. For manufacturers, the priority is pilot-scale validation under realistic thermal, mechanical, oxygen, and shelf-life conditions. For policymakers, the question is how to create standards that reward verified nutrient delivery rather than simply the amount of vitamin D3 declared at the point of manufacture.

A practical route forward for dairy fortification

When choosing between vitamin D3 microcapsules and oil emulsions, we should begin with the food vehicle and its failure points, not with the novelty of the carrier. A refrigerated dairy beverage, a fermented yogurt, and a powdered milk ingredient impose different demands. The technology must be matched to the product’s pH, processing temperature, oxygen exposure, storage duration, and distribution conditions.

A sensible development sequence is:

1. Define the nutrient-delivery target. Decide whether the priority is thermal survival, long-term retention, bioaccessibility, or a combination of these outcomes.

2. Screen the complete carrier system. Compare casein micelles, soy protein isolate emulsions, and oil-based nanoemulsions using the same product matrix and the same analytical methods.

3. Test the industrial process rather than an idealized treatment. Include homogenization, pumping, filling, light exposure, and realistic cold storage.

4. Measure both retention and bioaccessibility. A stable nutrient must still be released appropriately during digestion.

5. Assess production equity. Consider ingredient availability, equipment requirements, quality-control capacity, cost, and the ability of smaller producers to reproduce the formulation.

6. Set fortification standards around delivered performance. The public-health value lies in the nutrient that remains available in the food as consumed, not only in the amount added at the beginning.

The most promising direction is not a single universal carrier, but a more disciplined matching of delivery system to food vehicle and policy objective. Casein-based microcapsules may be especially valuable where dairy compatibility and heat protection are central. Optimized oil emulsions may remain highly practical where the production system is established and the oil phase can be selected for stability. Protein-stabilized emulsions offer another route when flexibility and protection must be balanced.

Vitamin D fortification will reach its full public-health potential only when formulation science and implementation policy move together. That means investing not just in better capsules or smaller droplets, but in process validation, transparent quality standards, accessible manufacturing infrastructure, and evidence that follows the nutrient all the way to the point of consumption. The systemic barrier is no longer simply whether vitamin D3 can be added to dairy. It is whether we can ensure that the vitamin survives the journey, product after product, community after community.